Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Utility of GATA3 in the Diagnosis of Urothelial Carcinomas With Variant Morphologic Patterns.

Applied immunohistochemistry & molecular morphology : AIMM - 1 Aug 2016

Verduin Lindsey, Mentrikoski Mark J, Heitz Christopher T, Wick Mark R

Abstract excerpt

The transcription factor GATA3 is a recently described biomarker that is highly expressed in bladder and breast carcinomas. Although it has shown sensitivity as a marker of primary bladder carcinomas with purely urothelial differentiation, the ability of GATA3 to label primary bladder carcinomas...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Carcinoma, Neuroendocrine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Renal Cell

Share to GATA3 Transcription Factor

Share to Immunohistochemistry

Share to Urinary Bladder Neoplasms

Share to Urologic Neoplasms

Source

Identifiers

PMID: 26317312
DOI: 10.1097/PAI.0000000000000221

Genes

GATA3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-26317312-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Utility of GATA3 in the Diagnosis of Urothelial Carcinomas With Variant Morphologic Patterns.PMID 26317312Read ↗

Diagnostic utility of GATA3 immunohistochemical expression in urothelial carcinomaSemantic proximity Read ↗

A Molecular Taxonomy for Urothelial CarcinomaSemantic proximity Read ↗

Gene of the month: GATA3.Semantic proximity Read ↗

Morphologic and Molecular Characteristics of Bladder Cancer.Semantic proximity Read ↗

FGFR3-Altered Urothelial Carcinoma: Clinicopathologic Observations With Emphasis on Variant Histology.Semantic proximity Read ↗

Plasmacytoid urothelial carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of a case series.Semantic proximity Read ↗

FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours.Semantic proximity Read ↗

FGFR3 and TP53 gene mutations define two distinct pathways in urothelial cell carcinoma of the bladder.Semantic proximity Read ↗

FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma.Semantic proximity Read ↗

Reassessment of p53 immunohistochemistry thresholds in invasive high grade bladder cancer shows a better correlation with TP53 and FGFR3 mutations.Semantic proximity Read ↗

Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome.Semantic proximity Read ↗

The FGFR3 mutation is related to favorable pT1 bladder cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.